论文信息 - Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy - 字舞流文

Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy

A. Longatto-Filho | F. Baltazar | D. Ferreira | L. Santos | J. Afonso | M. Costa | C. Gonçalves | A. Longatto‐Filho | Julieta Afonso